Gastrointestinal Stromal Tumor Drug and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Stromal Tumor (GIST) Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Stromal Tumor (GIST) Drug Overall Market Size
2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size: 2022 VS 2030
2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales: 2018-2030
3 Company Landscape
3.1 Top Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market
3.2 Top Global Gastrointestinal Stromal Tumor (GIST) Drug Companies Ranked by Revenue
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Companies
3.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Companies
3.5 Global Gastrointestinal Stromal Tumor (GIST) Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Gastrointestinal Stromal Tumor (GIST) Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market
3.8.1 List of Global Tier 1 Gastrointestinal Stromal Tumor (GIST) Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Markets, 2022 & 2030
4.1.2 Amcasertib
4.1.3 Anagrelide hydrochloride CR
4.1.4 APG-1351
4.1.5 Binimetinib
4.1.6 Others
4.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2023
4.2.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2024-2030
4.2.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
4.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
4.3.1 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2023
4.3.2 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2024-2030
4.3.3 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
4.4 By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2022 & 2030
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2023
5.2.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2024-2030
5.2.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
5.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
5.3.1 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2023
5.3.2 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2024-2030
5.3.3 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
5.4 By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2022 & 2030
6.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2023
6.2.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2024-2030
6.2.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
6.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales & Forecasts
6.3.1 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2023
6.3.2 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2024-2030
6.3.3 By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2030
6.4.2 By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2030
6.4.3 US Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.4.4 Canada Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.4.5 Mexico Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2030
6.5.2 By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2030
6.5.3 Germany Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.5.4 France Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.5.5 U.K. Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.5.6 Italy Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.5.7 Russia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.5.8 Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.5.9 Benelux Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2030
6.6.2 By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2030
6.6.3 China Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.6.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.6.5 South Korea Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.6.6 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.6.7 India Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2030
6.7.2 By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2030
6.7.3 Brazil Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.7.4 Argentina Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, 2018-2030
6.8.3 Turkey Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.8.4 Israel Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.8.5 Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
6.8.6 UAE Gastrointestinal Stromal Tumor (GIST) Drug Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Ariad Pharmaceuticals, Inc.
7.1.1 Ariad Pharmaceuticals, Inc. Company Summary
7.1.2 Ariad Pharmaceuticals, Inc. Business Overview
7.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.1.4 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.1.5 Ariad Pharmaceuticals, Inc. Key News & Latest Developments
7.2 Arog Pharmaceuticals, Inc.
7.2.1 Arog Pharmaceuticals, Inc. Company Summary
7.2.2 Arog Pharmaceuticals, Inc. Business Overview
7.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.2.4 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.2.5 Arog Pharmaceuticals, Inc. Key News & Latest Developments
7.3 Array BioPharma Inc.
7.3.1 Array BioPharma Inc. Company Summary
7.3.2 Array BioPharma Inc. Business Overview
7.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.3.4 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.3.5 Array BioPharma Inc. Key News & Latest Developments
7.4 Astex Pharmaceuticals, Inc.
7.4.1 Astex Pharmaceuticals, Inc. Company Summary
7.4.2 Astex Pharmaceuticals, Inc. Business Overview
7.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.4.4 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.4.5 Astex Pharmaceuticals, Inc. Key News & Latest Developments
7.5 Blueprint Medicines Corporation
7.5.1 Blueprint Medicines Corporation Company Summary
7.5.2 Blueprint Medicines Corporation Business Overview
7.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.5.4 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.5.5 Blueprint Medicines Corporation Key News & Latest Developments
7.6 Boston Biomedical, Inc.
7.6.1 Boston Biomedical, Inc. Company Summary
7.6.2 Boston Biomedical, Inc. Business Overview
7.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.6.4 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.6.5 Boston Biomedical, Inc. Key News & Latest Developments
7.7 Calithera Biosciences, Inc.
7.7.1 Calithera Biosciences, Inc. Company Summary
7.7.2 Calithera Biosciences, Inc. Business Overview
7.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.7.4 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.7.5 Calithera Biosciences, Inc. Key News & Latest Developments
7.8 Chipscreen Biosciences Ltd
7.8.1 Chipscreen Biosciences Ltd Company Summary
7.8.2 Chipscreen Biosciences Ltd Business Overview
7.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.8.4 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.8.5 Chipscreen Biosciences Ltd Key News & Latest Developments
7.9 Deciphera Pharmaceuticals, LLC
7.9.1 Deciphera Pharmaceuticals, LLC Company Summary
7.9.2 Deciphera Pharmaceuticals, LLC Business Overview
7.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.9.4 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.9.5 Deciphera Pharmaceuticals, LLC Key News & Latest Developments
7.10 F. Hoffmann-La Roche Ltd.
7.10.1 F. Hoffmann-La Roche Ltd. Company Summary
7.10.2 F. Hoffmann-La Roche Ltd. Business Overview
7.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.10.4 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.10.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.11 Horizon Pharma Plc
7.11.1 Horizon Pharma Plc Company Summary
7.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.11.4 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.11.5 Horizon Pharma Plc Key News & Latest Developments
7.12 Immunicum AB
7.12.1 Immunicum AB Company Summary
7.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.12.4 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.12.5 Immunicum AB Key News & Latest Developments
7.13 Jiangsu Hengrui Medicine Co., Ltd.
7.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Summary
7.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Business Overview
7.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.13.4 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.13.5 Jiangsu Hengrui Medicine Co., Ltd. Key News & Latest Developments
7.14 Kolltan Pharmaceuticals, Inc.
7.14.1 Kolltan Pharmaceuticals, Inc. Company Summary
7.14.2 Kolltan Pharmaceuticals, Inc. Business Overview
7.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.14.4 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.14.5 Kolltan Pharmaceuticals, Inc. Key News & Latest Developments
7.15 Natco Pharma Limited
7.15.1 Natco Pharma Limited Company Summary
7.15.2 Natco Pharma Limited Business Overview
7.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.15.4 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.15.5 Natco Pharma Limited Key News & Latest Developments
7.16 Nerviano Medical Sciences S.r.l.
7.16.1 Nerviano Medical Sciences S.r.l. Company Summary
7.16.2 Nerviano Medical Sciences S.r.l. Business Overview
7.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.16.4 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.16.5 Nerviano Medical Sciences S.r.l. Key News & Latest Developments
7.17 Novartis AG
7.17.1 Novartis AG Company Summary
7.17.2 Novartis AG Business Overview
7.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.17.4 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.17.5 Novartis AG Key News & Latest Developments
7.18 Omeros Corporation
7.18.1 Omeros Corporation Company Summary
7.18.2 Omeros Corporation Business Overview
7.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Major Product Offerings
7.18.4 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales and Revenue in Global (2018-2023)
7.18.5 Omeros Corporation Key News & Latest Developments
8 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, Analysis
8.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity, 2018-2030
8.2 Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Gastrointestinal Stromal Tumor (GIST) Drug Supply Chain Analysis
10.1 Gastrointestinal Stromal Tumor (GIST) Drug Industry Value Chain
10.2 Gastrointestinal Stromal Tumor (GIST) Drug Upstream Market
10.3 Gastrointestinal Stromal Tumor (GIST) Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Gastrointestinal Stromal Tumor (GIST) Drug in Global Market
Table 2. Top Gastrointestinal Stromal Tumor (GIST) Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Companies, 2018-2023
Table 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Type
Table 9. List of Global Tier 1 Gastrointestinal Stromal Tumor (GIST) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Stromal Tumor (GIST) Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2018-2023
Table 15. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2024-2030
Table 16. By Application ? Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2018-2023
Table 20. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2024-2030
Table 21. By Region ? Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2018-2023
Table 25. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), 2024-2030
Table 26. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2024-2030
Table 30. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2024-2030
Table 34. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2024-2030
Table 38. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2024-2030
Table 42. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales, (K Pcs), 2024-2030
Table 46. Ariad Pharmaceuticals, Inc. Company Summary
Table 47. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 48. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Ariad Pharmaceuticals, Inc. Key News & Latest Developments
Table 50. Arog Pharmaceuticals, Inc. Company Summary
Table 51. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 52. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Arog Pharmaceuticals, Inc. Key News & Latest Developments
Table 54. Array BioPharma Inc. Company Summary
Table 55. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 56. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. Array BioPharma Inc. Key News & Latest Developments
Table 58. Astex Pharmaceuticals, Inc. Company Summary
Table 59. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 60. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 61. Astex Pharmaceuticals, Inc. Key News & Latest Developments
Table 62. Blueprint Medicines Corporation Company Summary
Table 63. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 64. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 65. Blueprint Medicines Corporation Key News & Latest Developments
Table 66. Boston Biomedical, Inc. Company Summary
Table 67. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 68. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 69. Boston Biomedical, Inc. Key News & Latest Developments
Table 70. Calithera Biosciences, Inc. Company Summary
Table 71. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 72. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 73. Calithera Biosciences, Inc. Key News & Latest Developments
Table 74. Chipscreen Biosciences Ltd Company Summary
Table 75. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 76. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 77. Chipscreen Biosciences Ltd Key News & Latest Developments
Table 78. Deciphera Pharmaceuticals, LLC Company Summary
Table 79. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 80. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 81. Deciphera Pharmaceuticals, LLC Key News & Latest Developments
Table 82. F. Hoffmann-La Roche Ltd. Company Summary
Table 83. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 84. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 85. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 86. Horizon Pharma Plc Company Summary
Table 87. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 88. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 89. Horizon Pharma Plc Key News & Latest Developments
Table 90. Immunicum AB Company Summary
Table 91. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 92. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 93. Immunicum AB Key News & Latest Developments
Table 94. Jiangsu Hengrui Medicine Co., Ltd. Company Summary
Table 95. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 96. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 97. Jiangsu Hengrui Medicine Co., Ltd. Key News & Latest Developments
Table 98. Kolltan Pharmaceuticals, Inc. Company Summary
Table 99. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 100. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 101. Kolltan Pharmaceuticals, Inc. Key News & Latest Developments
Table 102. Natco Pharma Limited Company Summary
Table 103. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 104. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 105. Natco Pharma Limited Key News & Latest Developments
Table 106. Nerviano Medical Sciences S.r.l. Company Summary
Table 107. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 108. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 109. Nerviano Medical Sciences S.r.l. Key News & Latest Developments
Table 110. Novartis AG Company Summary
Table 111. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 112. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 113. Novartis AG Key News & Latest Developments
Table 114. Omeros Corporation Company Summary
Table 115. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offerings
Table 116. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 117. Omeros Corporation Key News & Latest Developments
Table 118. Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 119. Global Gastrointestinal Stromal Tumor (GIST) Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 120. Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region, 2018-2023 (K Pcs)
Table 121. Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Region, 2024-2030 (K Pcs)
Table 122. Gastrointestinal Stromal Tumor (GIST) Drug Market Opportunities & Trends in Global Market
Table 123. Gastrointestinal Stromal Tumor (GIST) Drug Market Drivers in Global Market
Table 124. Gastrointestinal Stromal Tumor (GIST) Drug Market Restraints in Global Market
Table 125. Gastrointestinal Stromal Tumor (GIST) Drug Raw Materials
Table 126. Gastrointestinal Stromal Tumor (GIST) Drug Raw Materials Suppliers in Global Market
Table 127. Typical Gastrointestinal Stromal Tumor (GIST) Drug Downstream
Table 128. Gastrointestinal Stromal Tumor (GIST) Drug Downstream Clients in Global Market
Table 129. Gastrointestinal Stromal Tumor (GIST) Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type in 2022
Figure 2. Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application in 2022
Figure 3. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, 2018-2030 (US$, Mn)
Figure 7. Gastrointestinal Stromal Tumor (GIST) Drug Sales in Global Market: 2018-2030 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Gastrointestinal Stromal Tumor (GIST) Drug Revenue in 2022
Figure 9. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 11. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 12. By Type - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs), 2018-2030
Figure 13. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 15. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 16. By Application - Global Gastrointestinal Stromal Tumor (GIST) Drug Price (USD/Pcs), 2018-2030
Figure 17. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 20. By Region - Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 21. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 22. By Country - North America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 23. US Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 28. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 29. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 37. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 41. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 43. By Country - South America Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 44. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share, 2018-2030
Figure 48. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Gastrointestinal Stromal Tumor (GIST) Drug Revenue, (US$, Mn), 2018-2030
Figure 52. Global Gastrointestinal Stromal Tumor (GIST) Drug Production Capacity (K Pcs), 2018-2030
Figure 53. The Percentage of Production Gastrointestinal Stromal Tumor (GIST) Drug by Region, 2022 VS 2030
Figure 54. Gastrointestinal Stromal Tumor (GIST) Drug Industry Value Chain
Figure 55. Marketing Channels
Industry Market Size
